Karen N. Prange

Karen N. Prange

DirectoratEmbecta· In proxies 2023–2024

Karen N. Prange sits on 8 public boards.

Boards1

  • EmbectaDirector · 1 yr on the boardIndependentAudit, Compensation and Management Development (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. EmbectaPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -78%
  2. AtriCure, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. BioMarin Pharmaceutical Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Nevro Corp.Public company
    • Director? – PresentNo stock prices for these years
  5. Aptinyx, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Cantel Medical CorporationPublic company
    • Director? – PresentNo stock prices for these years
  7. CarMax, Inc.Public company
    • Director? – PresentNo stock prices for these years
  8. ViewRay, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?